Publications

Read Now

June 2009 (Revised June 2009)
Case

VidaGas: VillageReach - The Mozambican Foundation for Community Development Joint Venture

This case describes the evolution of a liquid petroleum gas (LPG) distributor start-up, incubated by two not-for-profit NGOs to help improve the vaccine cold chain in Northern Mozambique. These NGOs must face the decision whether and how to sell their participation in... View Details

Keywords: Joint Ventures; Supply Chain; Health Care and Treatment; Investment; Non-Governmental Organizations; Energy Sources; Energy Industry; Health Industry; Mozambique

27 Jan 2015
News

Frustration with the Intracorporate Conspiracy Doctrine Distorts Other Areas of Law

July 1996 (Revised January 1997)
Case

Northwest Airlines: Strategic Alliance and Strategic Position--May 1996

By: Leonard A. Schlesinger and Davis Dyer

Describes the strategic position of Northwest Airlines in 1996 and discusses its financial rebound and changes and improvements since the 1993 restructuring agreement. Describes the company's new strategy and its management of principal strategic assets, focusing at... View Details

Keywords: Air Transportation; Restructuring; Alliances; Competitive Strategy; Government Administration; Cooperation; Business Strategy; Air Transportation Industry; United States; Netherlands

Find at Harvard

13 Dec 2022
Video

Santa Claus Debates Whether to Outsource Toy Production

May 2008
Article

Coerced Confessions: Self-Policing in the Shadow of the Regulator

By: Jodi L. Short and Michael W. Toffel

As part of a recent trend toward more cooperative relations between regulators and industry, novel government programs are encouraging firms to monitor their own regulatory compliance and voluntarily report their own violations. In this study, we examine how regulatory... View Details

Keywords: Governance Compliance; Law Enforcement; Corporate Disclosure; Governing Rules, Regulations, and Reforms; Environmental Sustainability; Programs; Power and Influence; Organizations; Decisions; Business and Government Relations; United States

Find at Harvard

Read Now

September 1991 (Revised February 1993)
Case

Burroughs Wellcome and AZT (A)

By: Willis M. Emmons III

Burroughs Wellcome Co., developer of AZT, the first drug approved by the U.S. Food and Drug Administration for the treatment of Acquired Immune Deficiency Syndrome (AIDS), finds itself under siege in September 1989 by AIDS activists and various segments of the U.S.... View Details

Keywords: Governing Rules, Regulations, and Reforms; Ethics; Business and Government Relations; Communication Strategy; Health Care and Treatment; Monopoly; Intellectual Property; Research and Development; Price; Pharmaceutical Industry; London

April 2014 (Revised July 2015)
Case

Sanofi Pasteur: The Dengue Vaccine Dilemma

By: V. Kasturi Rangan, David E. Bloom, Vincent Dessain and Emilie Billaud

In 2012, Sanofi Pasteur was racing to develop a vaccine against dengue, a mosquito-borne disease, and was evaluating this product in a Phase IIb trial conducted with school children in Thailand. But while the candidate vaccine met the high safety expectations and a... View Details

Keywords: Health Testing and Trials; Product Launch; Market Entry and Exit; Emerging Markets; Pharmaceutical Industry; France

January 2018
Case

Trian Partners' Proxy Contest at Procter & Gamble

By: Suraj Srinivasan and Quinn Pitcher

In July 2017, activist hedge fund Trian Partners announced that it was launching a proxy fight at U.S. consumer goods giant Procter & Gamble. P&G would be the largest company ever subjected to a proxy fight, as Trian sought to have its CEO, Nelson Peltz, elected to the... View Details

Keywords: Investment; Corporate Governance; Institutional Investing; Investment Activism; Business and Shareholder Relations; United States

30 Mar 2021
News

Remote Work Isn’t Going Anywhere. Here’s How You Can Still Succeed

16 May 2011
Research & Ideas

What Loyalty? High-End Customers are First to Flee

service quality are more or less immune from the high-end challenger. These findings suggest that before mounting a counterattack on a competitor's incursion, it's important to understand your customer priorities and your business's place... View Details

Keywords: by Julia Hanna

June 2002 (Revised November 2005)
Case

Life, Death, and Property Rights: The Pharmaceutical Industry Faces AIDS in Africa

By: Debora L. Spar

In the final years of the 20th century, the world was hit by a plague of epidemic proportions--AIDS, a life-threatening disease that remained stubbornly immune to any cure or vaccine. In the developed nations of the West, AIDS was slowly brought under control through a... View Details

Keywords: Patents; Health Pandemics; Corporate Social Responsibility and Impact; Pharmaceutical Industry; Africa

Research Summary

AIDS in Africa: Life, Death and Property Rights

By: Debora L. Spar

In the final years of the twentieth century, the world was hit by a plague of epidemic proportions--the plague of AIDS, a life-threatening disease that remained stubbornly immune to any cure or vaccine. In the developed nations of the West, AIDS was slowly brought... View Details

Web

Curriculum - MBA

cancer formation, including topics such as cancer epigenetic, tumor heterogeneity, systems biology proteomic approaches to study cancer, immune therapies in cancer, and therapeutic development. Biology of the Cancer Cell: From Molecular... View Details

Web

Capstone - MBA

go. Genetic engineering is one particularly promising type of therapy, in which patients’ own immune cells are altered to specifically target the cancer. This project described a next-generation approach to make this therapy more... View Details

13 Oct 2006
Working Paper Summaries

Coerced Confessions: Self-Policing in the Shadow of the Regulator

Keywords: by Jodi L. Short & Michael W. Toffel

September 2020
Case

Minerva 2020: Clinical Trials

By: John R. Wells and Benjamin Weinstock

In March 2020, Dr. Cynthia Bamdad, founder and CEO of Minerva Biotechnologies Inc. (Minerva), was reviewing the first results of human clinical trials for the company’s novel CAR-T drug therapeutic, one of the first ever to target solid cancer tumors. The results... View Details

Keywords: Biotechnology; Strategic Decision Making; Entrepreneurship; Health Testing and Trials; Decision Choices and Conditions; Strategy

October 2013
Article

Consulting on the Cusp of Disruption

By: Clayton M. Christensen, Dina Wang and Derek C. M. van Bever

Consulting fundamental business model has not changed in more than 100 years: very smart outsiders go into organizations for a finite period of time and recommend solutions for the most difficult problems confronting their clients. But at traditional... View Details

Keywords: Disruptive Innovation; Consulting Industry